↓ Skip to main content

Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection

Overview of attention for article published in BMC Infectious Diseases, December 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)

Mentioned by

blogs
2 blogs
twitter
4 tweeters

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
72 Mendeley
citeulike
1 CiteULike
Title
Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection
Published in
BMC Infectious Diseases, December 2010
DOI 10.1186/1471-2334-10-363
Pubmed ID
Authors

Milagros Gonzales, Jacques Pepin, Eric H Frost, Julie C Carrier, Stephanie Sirard, Louis-Charles Fortier, Louis Valiquette

Abstract

Oral vancomycin (125 mg qid) is recommended as treatment of severe Clostridium difficile infection (CDI). Higher doses (250 or 500 mg qid) are sometimes recommended for patients with very severe CDI, without supporting clinical evidence. We wished to determine to what extent faecal levels of vancomycin vary according to diarrhoea severity and dosage, and whether it is rational to administer high-dose vancomycin to selected patients.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Canada 1 1%
Unknown 70 97%

Demographic breakdown

Readers by professional status Count As %
Other 17 24%
Researcher 15 21%
Student > Ph. D. Student 7 10%
Student > Master 6 8%
Professor 6 8%
Other 21 29%
Readers by discipline Count As %
Medicine and Dentistry 36 50%
Agricultural and Biological Sciences 11 15%
Pharmacology, Toxicology and Pharmaceutical Science 7 10%
Unspecified 6 8%
Immunology and Microbiology 4 6%
Other 8 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 May 2019.
All research outputs
#961,186
of 13,396,110 outputs
Outputs from BMC Infectious Diseases
#220
of 4,989 outputs
Outputs of similar age
#12,155
of 149,359 outputs
Outputs of similar age from BMC Infectious Diseases
#1
of 1 outputs
Altmetric has tracked 13,396,110 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,989 research outputs from this source. They receive a mean Attention Score of 4.4. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 149,359 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them